SST-6007

Strategic Science & Technologies, LLC · Phase 2 active Small molecule

At a glance

Generic name	SST-6007
Sponsor	Strategic Science & Technologies, LLC
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SST-6007 CI brief — competitive landscape report
SST-6007 updates RSS · CI watch RSS
Strategic Science & Technologies, LLC portfolio CI